Commercialisation Officer, Faculty of Medicine

Ryhan Miah is a Commercialisation Officer within the Faculty of Medicine at 51³Ô¹ÏÍø, responsible for evaluating new inventions, managing IP protection, and driving collaboration between academics and industry partners. His work spans deep-tech innovation, sustainable chemical technologies and social enterprise engagement—advancing 51³Ô¹ÏÍø discoveries toward real-world impact through licensing and partnerships.

Ryhan holds an MChem in Chemistry with Medicinal Chemistry from Newcastle University and a Postgraduate Certificate in Intellectual Property from Bournemouth University. His combined scientific and IP background enables him to assess both technical merit and commercial potential, ensuring 51³Ô¹ÏÍø’s medical and scientific innovations reach global markets effectively.

Ryhan's portfolio

Discover all technologies

Oligonucleotide Suppression Of Let-7 Binding By H19 To Reduce Sensitivity To Inflammation

Oligonucleotide compositions targeting H19 enable Let-7 miRNA displacement, reducing inflammation and muscle wasting in tissue.

Management of pre-term labour via an application for pathway selective EP2 agonist

51³Ô¹ÏÍø’s EP2 agonist offers a long-acting, non-inflammatory tocolytic solution for managing pre-term labour effectively.

Methods to scale production of hPSC-derived endothelial cells

Scalable 3D bioreactor method yields stable hPSC-derived endothelial cells, overcoming limitations of 2D culture drift.